ArticleApoptosis : an international journal on programmed cell death2023

Exploratory study on the efficacy of bortezomib combining mitoxantrone or CD22-CAR T therapy targeting CD19-negative relapse after CD19-CAR T cell therapy with a simpler cell-line-based model.

Diandian Ba et al.PubMed ↗Publisher ↗

No numbers read from the abstract.